Sitryx names Adam Mostafa as chief financial officer Sep 8, 2025 07:00AM
Sitryx appoints Adam Mostafa as Chief Financial Officer Sep 8, 2025 07:00AM
Cantor Fitzgerald Reiterates Overweight Rating on X4 Pharmaceuticals (XFOR) Mar 26, 2025 06:45AM
X4 Pharmaceuticals to Participate in Upcoming September Investor Conferences Aug 28, 2024 08:00AM
X4 Pharmaceuticals (XFOR) Prices $65.0 Million Public Offering of Common Stock, Warrants Dec 7, 2022 08:43AM


Dec 7, 2022 08:43AM X4 Pharmaceuticals Prices $65.0 Million Public Offering
Dec 7, 2022 06:19AM X4 Pharmaceuticals (XFOR) to Offer Common Stock
Dec 6, 2022 06:26PM X4 Pharmaceuticals Announces Proposed Public Offering
Aug 3, 2021 08:00AM X4 Pharmaceuticals Announces Key Enrollment Milestone Achievements in Ongoing Mavorixafor Clinical Trials and Reports Second Quarter Financial Results
Sep 3, 2020 08:00AM X4 Pharmaceuticals to Participate in Three September Virtual Investor Conferences
Jun 22, 2020 07:06AM Companies with NDRs 6/22
May 19, 2020 06:48AM Companies with NDRs 5/19